StockData
Reviva Pharmaceuticals Holdings, Inc. logo

Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock

RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$0.45−0.02 (-4.36%)

Close on Oct 19, 2026Market cap $5.94MP/E –Yield –

Reviva Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Reviva Pharmaceuticals's total assets was $18.56M at Sep 30, 2026. For fiscal 2025 it was $15.92M, up 2.7% from the year before. The highest annual figure on record is $31.40M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$15.92M+2.7%
FY2024Dec 31, 2024$15.50M-34.6%
FY2023Dec 31, 2023$23.70M+25.2%
FY2022Dec 31, 2022$18.92M-39.7%
FY2021Dec 31, 2021$31.40M+258.4%
FY2020Dec 31, 2020$8.76M+336910.7%
FY2019Dec 31, 2019$2.60K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$18.56M+29.5%
Q2 FY2026Jun 30, 2026$21.14M+81.7%
Q1 FY2026Mar 31, 2026$23.56M+232.9%
Q4 FY2025Dec 31, 2025$15.92M+2.7%
Q3 FY2025Sep 30, 2025$14.33M+87.8%
Q2 FY2025Jun 30, 2025$11.63M+44.5%
Q1 FY2025Mar 31, 2025$7.08M-47.6%
Q4 FY2024Dec 31, 2024$15.50M-34.6%
Q3 FY2024Sep 30, 2024$7.63M+41.6%
Q2 FY2024Jun 30, 2024$8.05M-32.0%
Q1 FY2024Mar 31, 2024$13.50M+4.6%
Q4 FY2023Dec 31, 2023$23.70M+25.2%
Q3 FY2023Sep 30, 2023$5.39M-77.6%
Q2 FY2023Jun 30, 2023$11.84M-42.6%
Q1 FY2023Mar 31, 2023$12.90M-48.9%
Q4 FY2022Dec 31, 2022$18.92M-39.7%
Q3 FY2022Sep 30, 2022$24.04M-29.1%
Q2 FY2022Jun 30, 2022$20.64M-43.5%
Q1 FY2022Mar 31, 2022$25.27M+279.5%
Q4 FY2021Dec 31, 2021$31.40M+258.4%
Q3 FY2021Sep 30, 2021$33.89M-2.3%
Q2 FY2021Jun 30, 2021$36.53M+6.0%
Q1 FY2021Mar 31, 2021$6.66M-80.7%
Q4 FY2020Dec 31, 2020$8.76M+336910.7%
Q3 FY2020Nov 30, 2020$34.69M-47.8%
Q2 FY2020Aug 31, 2020$34.48M-48.0%
Q1 FY2020May 31, 2020$34.46M-47.8%
Q4 FY2019Dec 31, 2019$2.60K-100.0%
Q3 FY2019Nov 30, 2019$66.47M+2.2%
Q2 FY2019Aug 31, 2019$66.27M–
Q1 FY2019May 31, 2019$65.99M–
Q3 FY2018Nov 30, 2018$65.34M–
Q2 FY2018Aug 31, 2018$65.05M–

More Reviva Pharmaceuticals figures

See a number that looks wrong?